Clinical Trials Logo

Clinical Trial Summary

Osteoporosis is an important health problem in the rapidly-aging demographic. Fragility fractures are devastating consequences of osteoporosis. The most common treatment approach in osteoporosis is inhibition of bone resorption with drugs like alendronate (ALN). Parathyroid hormone (PTH) stimulates bone formation and is the only anabolic drug available. Dual therapy with ALN and PTH is not as effective as single-drug therapy in preventing fracture. Bone progenitor cells (MSCs) are recruited to sites of bone remodeling when a growth factor called Transforming Growth Factor Beta (TGF-β1) is released from bone. Different osteoporosis medicines may have differing effects on this process. The effects of ALN versus PTH on bone progenitor recruitment in humans are unknown. This is a randomized, clinical trial of ALN, PTH, and calcium and vitamin D in post-menopausal women with low bone mass. Women will be treated for 3 months with ALN or PTH or calcium and vitamin D. Data collected will include bone biopsies for histomorphometry and micro computed tomography (µCT), bone marrow aspirates for molecular studies, peripheral blood to detect circulating bone progenitor cells and dual X-ray absorptiometry. The investigators hypothesize that in humans, PTH will 1) increase bone progenitor number, 2) enhance recruitment of bone progenitor cells to bone resorption sites, and 3) increase bone progenitor number in peripheral circulation. Furthermore, the investigators hypothesize that ALN treatment will have the opposite effect. Understanding the differences in bone progenitor cell activity and recruitment during osteoporosis therapy will provide a mechanistic rationale for effective use of PTH and anti-resorptive drugs in osteoporosis treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01656629
Study type Interventional
Source Johns Hopkins University
Contact
Status Terminated
Phase N/A
Start date August 2012
Completion date August 7, 2020

See also
  Status Clinical Trial Phase
Completed NCT05457036 - Evaluation of the Effect of Spry Belt Treatment on Bone Turnover Marker Profile N/A
Completed NCT00588874 - Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis
Active, not recruiting NCT05283148 - Sickle Cell Disease (SCD) Bone Pain Study N/A
Recruiting NCT05245851 - Clinical Deployment and Validation of Rho N/A
Completed NCT00789503 - Nursing-Home Residents Given Bread Fortified With Vitamin D3 Phase 1/Phase 2
Completed NCT03761979 - Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults N/A
Active, not recruiting NCT05316272 - Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women N/A
Completed NCT00490906 - Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis N/A
Completed NCT00920075 - Alendronate in Juvenile Osteoporosis
Recruiting NCT00262184 - A Taiwan Isoflavone Multicenter Study (TIMS) N/A
Recruiting NCT05330546 - Evaluation of Implant Stability in Low Quality Bone Following The Use of Osseodensifiers Versus Ridge Expanders N/A